Animal Experiments



 

Experimental study on the safety of hyperthermic intracavitary chemotherapy

 

 

This project was funded by Natural Science Foundation of China (NSFC, No: 30973437)

 

Findings demonstrated

 

Impact of different HIPEC temperatures on the experimental canine vital signs and abdominal organs was observed. Findings demonstrated that 42℃~42.5℃ were safe during the HIPEC, and that the most effective intraperitoneal temperature for HIPEC is 42.5℃!

Equipment used for the experiment: Hyperthermic Intracavitary Chemotherapy Machine, Model GDPR-2100S

 

Animal experiments of comparing the flow rate and temperature with three ways of catheterization for the hyperthermic intraperitoneal chemotherapy

 
 

Funding source: Natural Science Foundation of China (NSFC, No: 81372608)

 

Findings demonstrated

 

Equipment used for the experiment: Hyperthermic Intracavitary Chemotherapy Machine, Model GDPR-2100S

Method: 4 thermometers were placed in the lower left, upper left, lower right, and upper right abdominal cavities, respectively, to measure the intraperitoneal temperature at each location.Data were analyzed by ANOVA

Results: Flow rate and temperature were measured multiple times from each animal of the 3 three groups; vital signs were stable during HIPEC procedure and all animals had good postoperative recovery

Conclusion: Although diameter of the catheters placed via puncture technique was smaller than that of the catheters placed via surgery, both Group B (Internal Medicine mode HIPEC with one In-flow and one Out-flow) and Group C (Internal Medicine mode HIPEC with 2 In-flow and 2 Out-flow) could achieve the flow rate and temperature levels of the Group A (Surgical mode HIPEC with 2 In-flow and 2 Out-flow), with less invasive, better repeatability, and thus, worthy clinical promotion.

 

Establishment of a micro-volume hyperthermic perfusion and circulation in the mouse peritoneal cavity via puncture technique

 
 

Findings demonstrated

 

A unique technique invented by the Scientists of Good Doctor; micro-volume hyperthermic perfusion and circulation via puncture technique; precisely performed HIPEC in a mouse model
Conducting hyperthermic perfusion and circulation with micro-volume of saline (≤ 100mL micro-circulation)

 

 

Good Doctor Animal Experiment | Safety Study of Intracavitary Circulatory Hyperthermic Perfusion Chemotherapy June 2012 Chinese Journal of Clinical Oncology - Vol. 39, No. 22

Good Doctor Animal Experiment | Animal experiment comparing the flow rate and temperature of intraperitoneal hyperthermic perfusion chemotherapy with three different catheterization methods August 2022 Modern Oncology Medicine - Volume 30, Issue 15

Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy

 

 

Xi'an Good Doctor Hyperthermic Perfusion Chemotherapy · Animal Experiment · Pioneering Technology · First Public Disclosure 

Against the backdrop of the increasingly widespread clinical application of tumor hyperthermic perfusion therapy, Xi’an Good Doctor Medical Science and Technology Co., Ltd. has, for the first time, publicly disclosed the results of three key animal experiments conducted during the R&D phase of its core technology. These experimental studies, spanning more than a decade, have provided robust animal experimental data supporting the safety and precision of intracavitary circulatory hyperthermic chemotherapy. They vividly demonstrate the company’s deep-rooted R&D expertise and solid technological strength in this field.